Familial Mediterranean Fever

This is a rare genetic condition that causes recurring episodes of fever, pain in the abdomen, headache, and rash. It can also cause inflammation in the lungs, joints, and sometimes the brain. People with this condition inherit it from their parents. It's passed down through families.

Condition

What people with Familial Mediterranean Fever report

Every report comes from a Lived member, sent anonymously.

Have you tried Colchicine for Familial Mediterranean Fever?

NameHow it went

About Familial Mediterranean Fever

What It Is

Familial Mediterranean fever (FMF) is an inherited condition that causes repeated attacks of fever and painful inflammation. Attacks most often affect the lining of the abdomen, causing intense belly pain, but they can also inflame the lining around the lungs (sharp chest pain that worsens with breathing) or a single large joint such as a knee or ankle. Some people also get a hot, red, painful rash on the lower legs. A typical attack lasts about 12 to 72 hours and then settles on its own, and between attacks most people feel completely well. FMF is an autoinflammatory disease, meaning the body's built-in inflammatory response switches on too easily and is slow to switch off. This is different from autoimmune diseases, where the immune system makes antibodies against the body's own tissues. The first attack usually happens in childhood or the teenage years. The condition matters beyond the attacks themselves: without treatment, long-running inflammation can lead to amyloidosis, a buildup of an abnormal protein in organs, especially the kidneys, which can progress to kidney failure.

Causes & Risk Factors

FMF is caused by changes (variants) in the MEFV gene, which carries instructions for pyrin, a protein in white blood cells that helps keep inflammation in check. It is usually inherited in an autosomal recessive pattern: a person typically has variants in both copies of the gene, one from each parent, while parents who carry a single copy are usually healthy. About a third of people with FMF have only one variant found on testing, and a few families show a pattern in which one copy seems to be enough, so inheritance is not always clear-cut. FMF is most common in people with roots in the eastern Mediterranean and Middle East, particularly Armenian, Turkish, Arab and Jewish (especially North African and other non-Ashkenazi) ancestry, where it affects roughly 1 in 200 to 1 in 1,000 people. It can occur in any population. Some variants, such as having two copies of one called M694V, are linked to more severe disease and a higher risk of amyloidosis. Many attacks come without warning, but some people notice that attacks follow particular triggers, such as emotional stress, infections, hard physical exertion, cold exposure, injury or surgery, or menstrual periods. These triggers set off attacks in someone who already has FMF; they do not cause the condition.

How It's Diagnosed

FMF is diagnosed mainly from the pattern of symptoms: repeated, short attacks of fever with belly, chest or joint pain, separated by symptom-free periods, often with a family history or relevant ancestry. Keeping a diary of when attacks happen, how long they last and what they involve is one of the most useful things a person can bring to an appointment. Blood tests taken during an attack usually show high levels of inflammation markers such as C-reactive protein (CRP) and the erythrocyte sedimentation rate (ESR), which tend to return to normal or near normal once the attack ends. That rise and fall helps separate FMF from conditions that cause constant inflammation. A urine test looks for protein, which can be an early sign of kidney involvement from amyloidosis. Genetic testing of the MEFV gene can support the diagnosis, and finding two disease-causing variants makes it very likely. A test that finds only one variant, or none, does not rule FMF out, so specialists weigh the genetic result alongside the history. Doctors also consider other causes of recurrent fever, including infections and other inherited fever syndromes. Because a belly attack can look like appendicitis, some people have abdominal surgery before FMF is recognized, which is one reason an early diagnosis matters. In uncertain cases, a clear improvement after starting colchicine also supports the diagnosis.

Treatment Options

There is no cure for FMF, but treatment is highly effective. The main treatment is colchicine (sold in the US as Colcrys and as generics), an anti-inflammatory tablet taken every day for life, starting soon after diagnosis. Most people taking it have far fewer and milder attacks, and many stop having them altogether. Just as importantly, daily colchicine protects against amyloidosis and kidney damage, even in people who still have some attacks. Its protection depends on steady use: it does not stop an attack that has already started, and skipped doses let inflammation return. Doctors adjust the dose to the person's age, attacks and blood test results. The most common side effects of colchicine are diarrhea, cramping, nausea and vomiting, which are usually mild and often ease with time or a dose adjustment. Colchicine has a narrow safety margin. Some other medicines, such as the antibiotic clarithromycin, certain antifungal and HIV medicines, and the transplant drug cyclosporine, can raise colchicine to dangerous levels, as can kidney or liver problems, so any new prescription should be checked against it. Overdose can be fatal, so tablets should be kept well out of children's reach. If a child swallows colchicine, or anyone takes more than prescribed, call Poison Control (1-800-222-1222) or 911 right away, even if they seem well, because the most serious effects can take a day or more to appear. About 1 in 20 people do not respond to the highest dose of colchicine they can tolerate, and a larger group responds only partly or cannot tolerate it. For them, injectable medicines that block interleukin-1 (IL-1), a key inflammatory signal in FMF, are the next step. Canakinumab (Ilaris) is FDA-approved for FMF, and anakinra (Kineret) is also used, though it is not specifically approved for FMF. These are usually added to colchicine rather than replacing it, and in studies most people taking them had their attacks controlled. Because they dampen part of the immune system, they increase the risk of infections and require planning around vaccines. During an attack, nonsteroidal anti-inflammatory drugs (NSAIDs), the family of pain relievers that includes ibuprofen, and rest can ease symptoms while the episode runs its course.

What to Expect

With consistent treatment, most people with FMF live full lives, working, studying, exercising and having families. Attacks tend to be most frequent and intense in the early years and may become milder or less frequent with age, though the pattern varies widely, even between relatives. People whose attacks are not fully controlled may still lose days to pain, fatigue and missed school or work, and that burden is worth raising at visits rather than accepting. Treatment is long-term, and follow-up is part of it. Specialists, usually rheumatologists, typically see people every 3 to 6 months after diagnosis or while attacks are uncontrolled, and about every 6 months once things are stable. Visits review attack frequency, side effects and whether doses are being taken, along with blood tests for inflammation between attacks and urine tests for protein. Ongoing low-level inflammation can be present even when someone feels well, and catching it is how treatment is adjusted to prevent amyloidosis. In children, growth and development are also monitored. Pregnancy is possible for people with FMF, and colchicine is generally continued during pregnancy and breastfeeding; studies have not shown higher rates of miscarriage or birth defects with it. Controlling inflammation also helps protect fertility, which can be reduced by untreated FMF. Because FMF is inherited, genetic counseling can help families understand the chances of passing it on and whether relatives should be checked.

When to Seek Help

Arrange an evaluation if you or your child keep having episodes of fever with belly, chest or joint pain that come and go, especially with a family history of FMF or relevant ancestry. Tell your care team at a routine visit if attacks are gradually becoming more frequent, or if treatment seems to be working less well than before. Contact them promptly if a single attack lasts much longer than usual, is more severe or feels different from your usual attacks, or if vomiting stops you from keeping colchicine down. Contact the prescriber promptly if you take colchicine and develop severe or ongoing diarrhea or vomiting, unusual muscle pain or weakness, or numbness or tingling, since these can be signs of too much colchicine in the body. Also contact them if you have a fever or signs of infection while taking an IL-1 blocker.

Questions to Ask Your Doctor

  1. 1.How sure are we that this is FMF, and what do my genetic test results mean for me and my family?
  2. 2.Which blood and urine tests will we use to check for hidden inflammation and kidney involvement, and how often?
  3. 3.What should I do if attacks continue even though I take colchicine every day?
  4. 4.Which of my other medicines, or ones I might be prescribed later, could interact with colchicine?
  5. 5.How should we plan treatment around pregnancy, breastfeeding or my child's growth?

Last reviewed • Oct 2026

Educational content, not medical advice.